Through a new acquisition, Amino Health will become Capital Rx’s patient-facing care navigation solution called Judi Care.

The post Capital Rx Expands Into Care Navigation with Acquisition of Amino Health appeared first on MedCity News.

Bristol Myers Squibb is licensing global rights to a Philochem program in development for both diagnostic imaging and targeted treatment of prostate cancer. It follows the pharma giant’s entry into radiopharmaceuticals via the $4.1 billion acquisition of RayzeBio last year.

The post Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to Prostate Cancer appeared first on MedCity News.

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than 1,000 employees this year; and moving to end billions in funds to partner institutions overseas.

The post ‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the Health of Americans’ appeared first on MedCity News.

Managing routine radiology does not require the administrative burden of prior authorization. Instead, health plans can implement post-service, pre-payment automated management based on clinical guidelines.

The post Managing Routine Radiology: An Opportunity to Control Costs and Improve Care appeared first on MedCity News.

[Sponsored] AI can free up 20% of nurses’ time by reducing documentation, which takes up to 60% of their shifts, helping combat burnout and improve patient care.

The post 7 Ways AI Is Helping Nurses and Transforming Healthcare appeared first on MedCity News.

Modern technology with AI at its center is creating unique opportunities to approach healthcare challenges in ways that weren’t possible just a few years back.

The post How Technology Is Personalizing Healthcare in 2025 appeared first on MedCity News.

Monarch, which launched Tuesday, provides the support and technology to help women’s health providers create their own independent practices.

The post Startup Launches to Help Women’s Health Providers Build Independent Practices appeared first on MedCity News.

[Sponsored] Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.

The post A Path to Healing: Discovering Arizona’s PTSD Treatment Centers appeared first on MedCity News.

Antares Therapeutics spun off of Scorpion Therapeutics, a clinical-stage biotech that Eli Lilly acquired earlier this year. Like Scorpion, Antares is developing small molecules that go after undruggable targets in cancer.

The post Cancer Drug Startup Antares Unveils $177M to Pick Up Where Scorpion Therapeutics Left Off appeared first on MedCity News.

Organizations need to take a proactive approach to identify, prioritize and mitigate threats in real time. This means gaining visibility and control into all physical and virtual assets.

The post A Preemptive Prescription to Cyber Exposure Management appeared first on MedCity News.

By reimagining the payment experience through transparency, flexibility, and technology, providers can drive better outcomes for both their bottom line and the patients they serve.

The post Improving Patient Payment Collections: Strategies for Success appeared first on MedCity News.

[Sponsored] Business banking provider* Mercury sponsored a webinar discussing early stage investment topics with venture capitalists such as grant funding secrets, capital valuation, the role of AI in life sciences, and more.

The post Investors Share How Early Stage Healthcare Startups Are Using AI appeared first on MedCity News.

FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on Immunization Practices; ACIP will have an entirely new roster at its next meeting after all 17 sitting members were dismissed by Health and Human Services Secretary Robert F. Kennedy Jr.

The post Merck RSV Drug for Infants Wins FDA Nod, But CDC Committee That Will Advise on Its Use Is Gutted appeared first on MedCity News.

GoodRx launched Community Link, a new cost-plus pricing program that allows independent pharmacies to contract directly with GoodRx.

The post GoodRx Unveils Cost-Plus Model for Independent Pharmacies appeared first on MedCity News.

The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials.

The post In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say appeared first on MedCity News.

The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation. 

The post Whole Eye Transplantation is No Longer Just Science Fiction appeared first on MedCity News.

Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a drug combination.

The post Metsera’s Amylin Drug Looks Good in Phase 1, Shows Potential to be a Once-Monthly Obesity Med appeared first on MedCity News.

EMS data is often the earliest signal of a looming public health crisis. By tapping into it in real time, agencies can detect overdose spikes, respiratory surges, or behavioral health trends days before traditional systems catch up.

The post The Hidden Frontline of Public Health: How EMS Data Is Powering a New Era of Syndromic Surveillance  appeared first on MedCity News.

[Sponsored] A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.

The post Navina’s AI Copilot Eases the Value-Based Burden, Study Shows appeared first on MedCity News.

The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment.

The post Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia appeared first on MedCity News.

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express Scripts are suing, claiming the law is unconstitutional.

The post Why CVS, Express Scripts Are Suing Over the Arkansas PBM Law appeared first on MedCity News.

Ardent Health is deploying virtual nurse technology to ease workflow burdens on bedside nurses by offloading routine tasks — and its nurse turnover rate has dropped from 15.5% to 9.5%. The health system is also using virtual specialty consults to enhance care in rural hospitals, cutting unnecessary transfers by 85% and enabling more patients to receive quality care close to home.

The post Virtual Nursing Saves Hospitals Money on Turnover Costs, Ardent Health CMO Says appeared first on MedCity News.

President Trump’s plan to fix IVF might look bold in a headline. In reality, it doesn’t create a single new embryology lab. It doesn’t hire one more specialist. It won’t change the fact that right now, only people with plenty of money can afford IVF, and throwing subsidies at a market that’s already bottlenecked only shifts who pays.

The post Making Insurance Cover IVF Could Actually Reduce Access appeared first on MedCity News.

Researchers and policymakers must challenge the default framing and stereotypical minority myth mindset which uniformly classifies AANHPI communities as low-risk, hindering both visibility and resource allocation. 

The post Overlooked in the Overdose Crisis: Addressing Substance Use Treatment for Asian American, Native Hawaiian, and Pacific Islander Communities appeared first on MedCity News.

In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary.

The post Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs appeared first on MedCity News.

When an attack or other issue occurs, the main difference between being down for months versus minutes or a day is having a mature and tested incident response plan. Without a plan, your cybersecurity team is flying blind, resulting in confusion and inefficiency that significantly slows your response time.

The post How Healthcare Can Reduce Cybersecurity Response Times from Hours to Minutes  appeared first on MedCity News.

The case for modernization isn’t solely about improving efficiency. It’s about equipping hospitals with the resources necessary to manage risk proactively, respond to negative trends quickly, and prioritize patient safety with high reliability.  

The post The Hidden Cost of Disconnected Quality Systems: Why Hospitals Should Modernize Now appeared first on MedCity News.

Hospitals saw improved financial performance during the first four months of the year, with operating margins rising to 3.3% thanks to higher patient volumes and more efficient throughput. However, experts warn that hospitals remain financially vulnerable as non-labor expenses continue to rise.

The post Hospitals See Financial Gains Due to Higher Volumes & Improved Throughput appeared first on MedCity News.

Amazon Pharmacy recently launched a new caregiver feature and expanded PillPack to Medicare Part D. The company says the updates will support medication adherence.

The post Amazon Pharmacy Brings PillPack to Medicare and Adds Caregiver Feature — Will It Make a Difference? appeared first on MedCity News.

Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s strategy for this drug in lung cancer and beyond.

The post J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma appeared first on MedCity News.